Expression of Metastasis-Associated Genesh-mts1(S100A4) andnm23in Carcinoma of Breast Is Related to Disease Progression
- 1 April 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 17 (4) , 335-342
- https://doi.org/10.1089/dna.1998.17.335
Abstract
The murine 18A2/mts1 and its human homolog h-mts1 (S100A4), encoding a Ca2+-binding protein belonging to the S-100 family, are associated with high invasive and metastatic potentials of murine tumors, human tumor cell lines in vitro, and human tumors growing as xenografts. The nm23 is a putative metastasis-suppressor gene whose expression has been found to correlate inversely with the metastatic potential of some forms of human cancer. The products of both human genes alter cytoskeletal dynamics, with antagonistic effects. In view of the equivocal association of nm23 with the metastatic potential of human cancer, we suspected that the relative expression of h-mts1 and nm23 might reflect tumor progression more accurately than either of them alone. We describe here the expression of these genes in infiltrating ductal carcinomas of the breast and show that high h-mts1 expression is associated with metastatic spread to the regional lymph nodes. The expression of nm23 on its own did not show a statistically significant inverse correlation with nodal spread. However, the expression status of the two genes, taken together, correlated strongly with the occurrence of nodal metastases. Breast cancers with no detectable expression of h-mts1 were found to be estrogen and progesterone receptor positive. Expression of h-mts1 was not related to tumor differentiation. The clinical data, together with the state of expression of steroid receptors and the expression levels of h-mts1 and nm23 genes, were analyzed using artificial neural networks for accuracy in predicting nodal spread of the carcinomas. These analyses support the conclusion that, overall, h-mts1 expression appears to be associated with and indicative of more aggressive disease. Complemented with nm23, h-mts1 could provide a powerful marker of breast cancer prognosis.Keywords
This publication has 34 references indexed in Scilit:
- Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomasHistopathology, 1996
- Elevated nm23 Protein Expression Is Correlated with Diminished Progression-Free Survival in Patients with Epithelial Ovarian CarcinomaGynecologic Oncology, 1996
- Epidermal Growth Factor Receptor Status Correlates with Cell Proliferation-related 18A2/mts1 Gene Expression in Human Carcinoma Cell LinesaAnnals of the New York Academy of Sciences, 1995
- Metastasis-Associatedmts1Gene Expression Correlates with Increased p53 Detection in the B16 Murine MelanomaDNA and Cell Biology, 1994
- Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomasVirchows Archiv B Cell Pathology Including Molecular Pathology, 1993
- Reduced Expression of nm23 Is Associated with Metastasis of Human Gastric CarcinomasJapanese Journal of Cancer Research, 1993
- Expression in Human Hepatocellular Carcinoma of Nucleoside Diphosphate Kinase, a Homologue of the nm23 Gene ProductJNCI Journal of the National Cancer Institute, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Estimation of epidermal growth factor receptor in 177 breast cancers: Correlation with prognostic factorsBreast Cancer Research and Treatment, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987